OMV (OMVJF) versus MDxHealth (MXDHF) Financial Contrast

OMV (OTCMKTS: OMVJF) and MDxHealth (OTCMKTS:MXDHF) are both oils/energy companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

Analyst Ratings

This is a summary of recent recommendations for OMV and MDxHealth, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OMV 0 0 0 0 N/A
MDxHealth 0 0 0 0 N/A


This table compares OMV and MDxHealth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OMV 1.09% 10.97% 5.13%
MDxHealth N/A N/A N/A

Valuation & Earnings

This table compares OMV and MDxHealth’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OMV $22.84 billion 0.83 $608.10 million $5.61 10.32
MDxHealth $40.51 million 6.36 -$14.99 million ($0.25) -17.20

OMV has higher revenue and earnings than MDxHealth. MDxHealth is trading at a lower price-to-earnings ratio than OMV, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

OMV has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of -0.58, meaning that its share price is 158% less volatile than the S&P 500.


OMV beats MDxHealth on 8 of the 9 factors compared between the two stocks.

OMV Company Profile

OMV Aktiengesellschaft operates as an integrated oil and gas company. It operates in two segments, Upstream and Downstream. The Upstream segment explores for, develops, and produces oil and gas resources primarily in Romania and Black Sea, Austria, North Sea, Australasia, the Middle East, and Africa. As of December 31, 2016, this segment had proved oil and gas reserve of 1,030 million barrels of oil equivalent; and proved and probable oil and gas reserves of 1,696 million barrels of oil equivalent. The Downstream segment refines, processes, and sells petroleum products to commercial and private customers. This segment operates refineries in Schwechat, Austria; Burghausen, Germany; and Petrobrazi, Romania with an annual processing capacity of 17.8 million metric tons, as well as operates a retail network of approximately 3,777 filling stations in 11 countries. This segment also engages in gas transit, as well as gas storage, marketing, and trading businesses. It operates a gas pipeline network; 4 gas storage facilities with a capacity of 2.7 billion cubic meters; and 2 gas-fired power plants in Romania and Turkey. The company was founded in 1956 and is headquartered in Vienna, Austria.

MDxHealth Company Profile

MDxHealth SA, a molecular diagnostics company, develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients in Belgium and internationally. The company's tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's products include ConfirmMDx, a solution for prostate cancer testing; and SelectMDx, a pre-biopsy diagnostic tool for prostate cancer. Its product pipeline includes tests for bladder, kidney, and other urologic cancers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.

Receive News & Ratings for OMV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OMV and related companies with's FREE daily email newsletter.

Leave a Reply